CLASS II Drug recall · Reported 10 Sep 2014 · FDA Enforcement Report

Paxil (Paroxetine HCL) Oral Suspension 10 mg recalled by Apotex

Apotex is recalling Paxil (Paroxetine HCL) Oral Suspension 10 mg, distributed nationwide in the US. The recall was initiated on 24 Mar 2014 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesLot # 2A001, Exp. 01/15; Lot # 2C002, Exp. 03/15
Quantity recalled13,429 bottles

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

Recall details

Recall number
D-1575-2014
FDA event ID
68967
Recalling firm
Apotex, Toronto
Classification
Class II
Status
Terminated
Recall initiated
24 Mar 2014
FDA classified
3 Sep 2014
Reported
10 Sep 2014
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Other Reasons
Drug class
Antidepressants

Timeline

24 Mar 2014Recall initiated by company
3 Sep 2014Classified by FDA+163 days
10 Sep 2014Published in enforcement report+7 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Chemical Contamination: Product were manufactured with active pharmaceutical ingredient (API) batches contaminated with residual materials and solvents.

Product as listed by the FDA

PAXIL (Paroxetine HCL) Oral Suspension 10 mg/5 mL - 250 mL bottle, Rx Only, Manufactured by GlaxoSmithKline, RTP, NC 27709. Distributed by Apotex Corp., Westin, FL 33326, NDC 60505-0402-5

Where it was distributed

Nationwide and Puerto Rico

Nationwide Puerto Rico

Questions about this recall

Why was it recalled?

Chemical Contamination: Product were manufactured with active pharmaceutical ingredient (API) batches contaminated with residual materials and solvents.

Which lots are affected?

Lot # 2A001, Exp. 01/15; Lot # 2C002, Exp. 03/15

Where was it sold?

Nationwide and Puerto Rico

What should I do if I have it?

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

Other products in this recall event

8 other products · FDA event 68967

This product is part of a recall event; the main page for the event is Paroxetine HCL Controlled-Release Tablets 25 mg recalled by Apotex.

More recalls from Apotex

All 75
ReportedClassRecallCompanyReasonWhere
DrugCLASS IIPaxil CR, Paroxetine, Extended-Release Tablets, 37.5mg recalledApotexPotency & AssayNationwide
DrugCLASS IIDesmopressin Nasal Spray, USP, 10 mcg/ bottle (50 doses) recalledApotexOtherNationwide
DrugCLASS IIBrimonidine Tartrate/Timolol Maleate Ophthalmic Solution 0.2%/0.5%* recalledBrimonidine Tartrate/timolol Maleate Ophthalmic SolutionApotexSterilityNationwide
DrugCLASS IIKetorolac Tromethamine Ophthalmic Solution recalled by ApotexKetorolac TromethamineApotexSterilityNationwide
DrugCLASS IIBrimonidine Tartrate/Timolol Maleate Ophthalmic Solution recalledBrimonidine Tartrate/timolol Maleate Ophthalmic SolutionApotexSterilityNationwide

Other Paxil (paroxetine recalls

All 6
ReportedClassRecallCompanyReasonWhere
DrugCLASS IIPaxil (Paroxetine HCL) Tablets 20 mg recalled by ApotexApotexOtherNationwide
DrugCLASS IIPaxil CR (Paroxetine HCL) Controlled-Release Tablets 25 mg recalledApotexOtherNationwide
DrugCLASS IIPaxil CR (Paroxetine HCL) Controlled-Release Tablets 37.5 mg recalledApotexOtherNationwide
DrugCLASS IIPaxil (Paroxetine HCL) Tablets 10 mg recalled by ApotexApotexOtherNationwide
DrugCLASS IIPaxil (Paroxetine HCL) Tablets 40 mg recalled by ApotexApotexOtherNationwide